Doppler assessment of the renal blood flow velocity waveform during indomethacin therapy for preterm labor and polyhydramnios.
To investigate the effects of indomethacin on the human fetal renal blood flow velocity waveform, 17 fetuses whose mothers were treated for preterm labor (N = 8) or polyhydramnios (N = 9) were studied. There were five growth-retarded fetuses (all in the group with polyhydramnios), 11 normal fetuses, and one fetus with red-cell alloimmunization. The indomethacin dose in all patients was 25 mg orally every 6 hours. The gestational age of the fetuses studied varied between 24-35 weeks (mean +/- SD 29.6 +/- 2.8). The fetal renal artery was studied at its origin from the aorta before and during the first 24 hours of indomethacin therapy. Seven fetuses manifested ductal constriction. Three fetuses also manifested tricuspid regurgitation. All ductal constrictions and the tricuspid regurgitations resolved in utero after discontinuation of indomethacin. There were no significant differences in the pulsatility index values of the renal artery before and during indomethacin therapy. These results suggest that there is no change in fetal renovascular parameters detectable with pulsatility index measurements during the first 24 hours of maternal indomethacin therapy.
Mari
G
G
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.
Moise
K J
KJ
Deter
R L
RL
Kirshon
B
B
Carpenter
R J
RJ
D004373:Ductus Arteriosus / Q000187:drug effects; D005260:Female; D005323:Fetal Monitoring; D005865:Gestational Age; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects* / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000196:embryology*; D008431:Maternal-Fetal Exchange; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D006831:Polyhydramnios / Q000188:drug therapy*; D011247:Pregnancy; D011673:Pulsatile Flow; D012079:Renal Circulation / Q000187:drug effects; D014262:Tricuspid Valve Insufficiency / Q000139:chemically induced; D014463:Ultrasonography
D007213:Indomethacin